BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced its third quarter 2009 financial results.
BioSante incurred a net loss of approximately $6.4 million or ($0.21) per share for the quarter ended September 30, 2009, compared to a net loss of $6.6 million or ($0.24) per share for the same period in 2008. This decrease in net loss was [...]

Continue reading " BioSante Pharmaceuticals Reports Third Quarter 2009 Financial Results "

Human immune cells communicate constantly with one another as they coordinate to fight off infection and other threats. Now researchers at Stanford University’s School of Medicine have shown that muffling a key voice in this conversational patter is an early step in the progression of human cancers. Silencing an inter-cell signaling mechanism called the interferon [...]

Continue reading " Disruption of Immune-System Pathway Key Step in Cancer Progression, Stanford Study Shows "